Patents by Inventor Allan Weissman

Allan Weissman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ube2g2 binding domain in the ubiquitin ligase gp78 and methods of use thereof
    Patent number: 8420776
    Abstract: The present invention features isolated nucleic acid molecules, designated G2BD nucleic acid molecules, which encode the binding site from the gp78 ubiquitin ligase that binds to the Ube2G2 ubiquitin conjugating enzyme. The invention further provides isolated G2BD proteins and fusion proteins. Still further provided are diagnostic and therapeutic methods, as well as screening assays utilizing compositions of the invention.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: April 16, 2013
    Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Allan Weissman, Jennifer Mariano, Bo Chen, Yien Che Tsai
  • HIGHLY SOLUBLE PYRIMIDO-DIONE-QUINOLINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
    Publication number: 20100056549
    Abstract: The present invention features pyrimido-dione-quinoline compounds having improved solubility, pharmaceutical compositions of substituted pyrimido-dione-quinoline compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more pyrimido-dione-quinoline compounds of the invention.
    Type: Application
    Filed: June 13, 2007
    Publication date: March 4, 2010
    Applicant: Government of the US, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Allan Weissman, Yili Yang
  • Ube2g2 Binding Domain in The Ubiquitin Ligase Gp78 And Methods Of Use Thereof
    Publication number: 20080090249
    Abstract: The present invention features isolated nucleic acid molecules, designated G2BD nucleic acid molecules, which encode the binding site from the gp78 ubiquitin ligase that binds to the Ube2G2 ubiquitin conjugating enzyme. The invention further provides isolated G2BD proteins and fusion proteins. Still further provided are diagnostic and therapeutic methods, as well as screening assays utilizing compositions of the invention.
    Type: Application
    Filed: April 27, 2005
    Publication date: April 17, 2008
    Applicant: Government of the US, as represented by the Secretary, Department fo Health and Human Services
    Inventors: Allan Weissman, Jennifer Mariano, Bo Chen, Yien Tsai
  • Deazaflavin compounds and methods of use thereof
    Publication number: 20060211718
    Abstract: The present invention features 5-deazaflavin compounds, pharmaceutical compositions of 5-deazaflavin compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more 5-deazaflavin compounds of the invention.
    Type: Application
    Filed: February 12, 2004
    Publication date: September 21, 2006
    Applicants: GOVERNMENT OF THE US, AS REPRESENTED BY THE SEC- RETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, BioVERIS CORPORATION
    Inventors: Allan Weissman, Karen Vousden, Jane Jensen, Yili Yang, Shengyun Fang, Douglas Woods, John Kenten, Ilia Davydov, Yassamin Safiran, Pankaj Oberoi